Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells

Cholangiocarcinoma (CCA) is a lethal bile duct cancer that responds poorly to current standard treatments. A new therapeutic approach is, therefore, urgently needed. Adoptive T cell transfer using chimeric antigen receptor (CAR) T cells is a new therapeutic modality with demonstrated efficacy in hem...

Full description

Bibliographic Details
Main Authors:	Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri, Thaweesak Chieochansin, Jatuporn Sujjitjoon, Sopit Wongkham, John Maher, Mutita Junking, Pa-thai Yenchitsomanus
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Oncology
Subjects:	adoptive T cell therapy chimeric antigen receptor integrin αvβ6 immunotherapy cholangiocarcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.657868/full

Similar Items

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma
by: Kamonlapat Supimon, et al.
Published: (2021-03-01)

Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA
by: Mutita Junking, et al.
Published: (2017-10-01)

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction
by: Jatuporn Sujjitjoon, et al.
Published: (2021-02-01)

Molecular Genetics of Diabetes Mellitus
by: Nattachet Plengvidhya, et al.
Published: (2008-09-01)

A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by <i>Butea monosperma</i> Agglutinin
by: Karuntarat Teeravirote, et al.
Published: (2021-05-01)

Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
by: Prin Sungwan, et al.
Published: (2021-03-01)

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma
by: Sawanyawisuth Kanlayanee, et al.
Published: (2011-08-01)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
by: Nathakan Klinhom-on, et al.
Published: (2021-04-01)

Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma
by: Doungdean Tummanatsakun, et al.
Published: (2019-08-01)

High Monopolar Spindle 1 Is Associated with Short Survival of Cholangiocarcinoma Patients and Enhances the Progression Via AKT and STAT3 Signaling Pathways
by: Piya Prajumwongs, et al.
Published: (2021-01-01)

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
by: Kulthida Vaeteewoottacharn, et al.
Published: (2019-05-01)

Adaptor Protein 1A Facilitates Dengue Virus Replication.
by: Umpa Yasamut, et al.
Published: (2015-01-01)

A novel predictive equation for potential diagnosis of cholangiocarcinoma.
by: Ratthaphol Kraiklang, et al.
Published: (2014-01-01)

Cancer review: Cholangiocarcinoma
by: Yezaz Ahmed Ghouri, et al.
Published: (2015-01-01)

Molecular Genetics and Genomics in Medicine
by: Pa-thai Yenchitsomanus
Published: (2008-09-01)

Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma
by: Kern Rei Chng, et al.
Published: (2016-06-01)

Novel adiponectin variants identified in type 2 diabetic patients reveal multimerization and secretion defects.
by: Prapaporn Jungtrakoon, et al.
Published: (2011-01-01)

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells
by: Penkhae Utaijaratrasmi, et al.
Published: (2018-01-01)

Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma
by: Sirinapa Sribenja, et al.
Published: (2016-07-01)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)

Phylogenetic molecular evolution and recombination analysis of complete genome of human parechovirus in Thailand
by: Thaweesak Chieochansin, et al.
Published: (2021-04-01)

Cholangiocarcinoma with Lymphoepithelioma-like Component not Associated with Epstein-Barr Virus
by: Wen-Han Chang, et al.
Published: (2015-12-01)

Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma
by: Kanlayanee Sawanyawisuth, Ph.D., et al.
Published: (2016-01-01)

Resection of intrahepatic cholangiocarcinoma in elderly patients – is it reasonable?
by: Fabian Bartsch, et al.
Published: (2019-10-01)

Intrahepatic Cholangiocarcinoma Associated with Intrahepatic Duct Stones
by: Hoon Hur, et al.
Published: (2009-01-01)

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
by: Saowaluk Saisomboon, et al.
Published: (2019-05-01)

Vascular Resection for Intrahepatic Cholangiocarcinoma: Current Considerations
by: Ruslan Alikhanov, et al.
Published: (2021-08-01)

O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma
by: Chatchai Phoomak, et al.
Published: (2019-02-01)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
by: Hai-Chun Zhang, et al.
Published: (2020-10-01)

Targeted Therapies in Advanced Cholangiocarcinoma: A Focus on FGFR Inhibitors
by: Alessandro Rizzo
Published: (2021-05-01)

Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.
by: Wunchana Seubwai, et al.
Published: (2014-01-01)

The miRNAome of Opisthorchis viverrini induced intrahepatic cholangiocarcinoma
by: Jin Peng, et al.
Published: (2014-12-01)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
by: Jennifer Sammon, et al.
Published: (2018-02-01)

Multiple cholangiocarcinomas in the intrahepatic and extrahepatic biliary tree due to dichloromethane exposure: a case report
by: Daisuke Ogawa, et al.
Published: (2020-04-01)

Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
by: Kai-chao Feng, et al.
Published: (2017-01-01)

Sarcomatoid change in intrahepatic cholangiocarcinoma
by: Albrechtsen Wewer Nicolai, et al.
Published: (2013-03-01)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
by: Yoshiyuki Inoue, et al.
Published: (2012-01-01)

SARCOMATOID CHANGE IN INTRAHEPATIC CHOLANGIOCARCINOMA
by: Wewer Albrechtsen, et al.
Published: (2013-01-01)

Cutaneous Metastasis of Cholangiocarcinoma: Report of Two Cases
by: B Geramizadeh, et al.
Published: (2013-10-01)

Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma
by: Kathy P. Willowson, et al.
Published: (2021-09-01)